ZA201001064B - Triazole compounds that modulate Hsp90 activity - Google Patents
Triazole compounds that modulate Hsp90 activityInfo
- Publication number
- ZA201001064B ZA201001064B ZA201001064A ZA201001064A ZA201001064B ZA 201001064 B ZA201001064 B ZA 201001064B ZA 201001064 A ZA201001064 A ZA 201001064A ZA 201001064 A ZA201001064 A ZA 201001064A ZA 201001064 B ZA201001064 B ZA 201001064B
- Authority
- ZA
- South Africa
- Prior art keywords
- triazole compounds
- hsp90 activity
- modulate hsp90
- modulate
- activity
- Prior art date
Links
- 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 title 1
- 101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 title 1
- -1 Triazole compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
- C07F9/6518—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96444707P | 2007-08-13 | 2007-08-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201001064B true ZA201001064B (en) | 2010-10-27 |
Family
ID=39884398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA201001064A ZA201001064B (en) | 2007-08-13 | 2010-02-12 | Triazole compounds that modulate Hsp90 activity |
Country Status (14)
Country | Link |
---|---|
US (3) | US8742133B2 (xx) |
EP (1) | EP2193135A1 (xx) |
JP (1) | JP5596543B2 (xx) |
KR (1) | KR20100057030A (xx) |
CN (1) | CN101801983B (xx) |
AU (1) | AU2008287367B2 (xx) |
BR (1) | BRPI0815116A2 (xx) |
CA (1) | CA2695995C (xx) |
IL (1) | IL203663A (xx) |
MX (1) | MX2010001565A (xx) |
NZ (1) | NZ583205A (xx) |
TW (1) | TWI438199B (xx) |
WO (1) | WO2009023211A1 (xx) |
ZA (1) | ZA201001064B (xx) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1817295B1 (en) | 2004-11-18 | 2012-11-07 | Synta Pharmaceuticals Corp. | Triazole compounds that modulate hsp90 activity |
CA2618377A1 (en) | 2005-08-12 | 2007-02-22 | Synta Pharmaceuticals Corp. | Pyrazole compounds that modulate hsp90 activity |
US20070250391A1 (en) * | 2006-04-05 | 2007-10-25 | Prade Hendrik D | Merchandising system and method for food and non-food items for a meal kit |
RS53446B (en) | 2006-05-25 | 2014-12-31 | Synta Pharmaceuticals Corp. | TRIAZOLE UNITS MODULATING HSP90 ACTIVITY |
AU2007267847B2 (en) | 2006-05-25 | 2012-04-12 | Synta Pharmaceuticals Corp. | Triazole compounds that modulate Hsp90 activity |
US20080027047A1 (en) * | 2006-05-25 | 2008-01-31 | Weiwen Ying | Compounds that modulate HSP90 activity and methods for identifying same |
US8063083B2 (en) | 2006-05-25 | 2011-11-22 | Synta Pharmaceuticals Corp. | Method for treating non-Hodgkin's lymphoma |
US8034834B2 (en) | 2006-05-25 | 2011-10-11 | Synta Pharmaceuticals Corp. | Method for treating proliferative disorders with HSP90 inhibitors |
AU2008214279B2 (en) | 2007-02-08 | 2012-08-16 | Synta Pharmaceuticals Corp. | Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer |
BRPI0815116A2 (pt) | 2007-08-13 | 2015-01-27 | Synta Pharmaceuticals Corp | Compostos de triazol que modulam a atividade da hsp90 |
US9156836B2 (en) * | 2008-05-16 | 2015-10-13 | Synta Pharmaceuticals Corp. | Tricyclic triazole compounds that modulate HSP90 activity |
WO2009148599A1 (en) | 2008-06-04 | 2009-12-10 | Synta Pharmaceuticals Corp. | Pyrrole compunds that modulate hsp90 activity |
US8648071B2 (en) | 2008-06-27 | 2014-02-11 | Synta Pharmaceuticals Corp. | Hydrazonamide compounds that modulate Hsp90 activity |
US9126953B2 (en) * | 2008-08-08 | 2015-09-08 | Synta Pharmaceuticals Corp. | Triazole compounds that modulate HSP90 activity |
EP2323737A2 (en) | 2008-08-08 | 2011-05-25 | Synta Pharmaceuticals Corp. | Triazole compounds that modulate hsp90 activity |
FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
KR20120093970A (ko) * | 2009-10-19 | 2012-08-23 | 신타 파마슈티칼스 코프. | 에이취에스피90 억제 화합물을 이용한 조합 항암 요법 |
US20130156755A1 (en) | 2010-04-19 | 2013-06-20 | Synta Pharmaceuticals Corp. | Cancer therapy using a combination of a hsp90 inhibitory compounds and a vegf inhibitor |
EP2560640A1 (en) | 2010-04-19 | 2013-02-27 | Synta Pharmaceuticals Corp. | Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor |
WO2011146803A1 (en) | 2010-05-20 | 2011-11-24 | Synta Pharmaceuticals Corp. | Method of treating lung adenocarcinoma with hsp90 inhibitory compounds |
US20130172333A1 (en) | 2010-05-20 | 2013-07-04 | Synta Pharmaceuticals Corp. | Formulation and dosing of hsp90 inhibitory compounds |
WO2011149824A1 (en) | 2010-05-24 | 2011-12-01 | Synta Pharmaceuticals Corp. | Cancer therapy using a combination of a hsp90 inhibitory compound and a topoisomerase ii inhibitor |
BR112013004258A2 (pt) * | 2010-08-23 | 2016-08-02 | Daiichi Sankyo Co Ltd | cristal, composição farmacêutica, e, agente anticâncer |
US9089570B2 (en) * | 2010-09-03 | 2015-07-28 | Tactical Therapeutics Inc | Compositions for treating cancers having acquired resitance to prior chemotherapeutic and targeted drugs using carboxyamidotriazole orotate |
AU2011302344B2 (en) | 2010-09-13 | 2015-01-15 | Synta Pharmaceuticals Corp. | HSP90 inhibitors for treating non-small cell lung cancers in wild-type EGFR and/or KRAS patients |
US20140005145A1 (en) | 2010-12-08 | 2014-01-02 | Synta Pharmaceuticals Corp. | Combination breast cancer therapy with hsp90 inhibitory compounds |
WO2012096919A1 (en) | 2011-01-11 | 2012-07-19 | Synta Pharmaceuticals Corp. | Combination therapy of hsp90 inhibitory compounds with proteasome inhibitors |
WO2012116061A1 (en) | 2011-02-23 | 2012-08-30 | Synta Pharmaceuticals Corp. | Combination therapy of hsp90 inhibitory compounds with radiotherapy |
JP2014507443A (ja) | 2011-02-24 | 2014-03-27 | シンタ ファーマシューティカルズ コーポレーション | Hsp90阻害化合物での前立腺癌治療 |
WO2012116247A1 (en) | 2011-02-25 | 2012-08-30 | Synta Pharmaceuticals Corp. | Hsp90 inhibitory compounds in treating jak/stat signaling-mediated cancers |
US20140228418A1 (en) * | 2011-05-23 | 2014-08-14 | Synta Pharmaceuticals Corp. | Combination therapy of hsp90 inhibitory compounds with mek inhibitors |
US20140315943A1 (en) | 2011-05-24 | 2014-10-23 | Synta Pharmaceuticals Corp. | Combination therapy of hsp90 inhibitory compounds with mtor/p13k inhibitors |
EP2714033A1 (en) * | 2011-05-26 | 2014-04-09 | Synta Pharmaceuticals Corp. | Combination therapy of hsp90 inhibitory compounds with chk inhibitors |
EP2729144A2 (en) | 2011-07-07 | 2014-05-14 | Synta Pharmaceuticals Corp. | Treating cancer with hsp90 inhibitory compounds |
US9439899B2 (en) | 2011-11-02 | 2016-09-13 | Synta Pharmaceuticals Corp. | Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhibitors |
JP2014534228A (ja) * | 2011-11-02 | 2014-12-18 | シンタ ファーマシューティカルズ コーポレーション | 白金含有剤とhsp90阻害剤の組合せ療法 |
WO2013074594A1 (en) | 2011-11-14 | 2013-05-23 | Synta Pharmaceuticals Corp. | Combination therapy of hsp90 inhibitors with braf inhibitors |
JP2015515477A (ja) * | 2012-04-04 | 2015-05-28 | シンタ ファーマシューティカルズ コーポレーション | Hsp90活性を調節する新規トリアゾール化合物 |
WO2013170159A1 (en) | 2012-05-10 | 2013-11-14 | Synta Pharmaceuticals Corp. | Treating cancer with hsp90 inhibitory compounds |
CN103664910B (zh) * | 2012-09-14 | 2017-07-04 | 南京大学 | 含1,4‑苯并二噁烷的1,2,4‑三氮唑类衍生物及其制法与其抗菌活性 |
KR101941004B1 (ko) * | 2013-03-25 | 2019-01-23 | 주식회사 엘지화학 | 조절 t 세포로의 분화 유도 및 증식 촉진을 통한 면역 반응 억제용 약학 조성물 |
JP6497767B2 (ja) | 2013-12-16 | 2019-04-10 | 日本化薬株式会社 | 癌治療におけるhsp90阻害剤の抗腫瘍効果を予測する方法 |
US11497733B2 (en) | 2015-02-09 | 2022-11-15 | Synta Pharmaceuticals Corp. | Combination therapy of HSP90 inhibitors and PD-1 inhibitors for treating cancer |
SI3300500T1 (sl) | 2015-05-20 | 2020-07-31 | Amgen Inc. | Triazolni agonisti receptorja APJ |
US9988369B2 (en) | 2016-05-03 | 2018-06-05 | Amgen Inc. | Heterocyclic triazole compounds as agonists of the APJ receptor |
EP3541810B1 (en) | 2016-11-16 | 2020-12-23 | Amgen Inc. | Triazole phenyl compounds as agonists of the apj receptor |
US11191762B2 (en) | 2016-11-16 | 2021-12-07 | Amgen Inc. | Alkyl substituted triazole compounds as agonists of the APJ Receptor |
EP3541803B1 (en) | 2016-11-16 | 2020-12-23 | Amgen Inc. | Triazole pyridyl compounds as agonists of the apj receptor |
EP3541792B1 (en) | 2016-11-16 | 2020-12-23 | Amgen Inc. | Triazole furan compounds as agonists of the apj receptor |
EP3541804A1 (en) | 2016-11-16 | 2019-09-25 | Amgen Inc. | Cycloalkyl substituted triazole compounds as agonists of the apj receptor |
EP3541805B1 (en) | 2016-11-16 | 2020-10-14 | Amgen Inc. | Heteroaryl-substituted triazoles as apj receptor agonists |
US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
EP3704122B1 (en) | 2017-11-03 | 2021-09-01 | Amgen Inc. | Fused triazole agonists of the apj receptor |
WO2019213006A1 (en) | 2018-05-01 | 2019-11-07 | Amgen Inc. | Substituted pyrimidinones as agonists of the apj receptor |
WO2021119358A1 (en) * | 2019-12-10 | 2021-06-17 | Washington University | Debaryomyces species as an indicator of non-healing ulcers in crohn's disease |
WO2022187287A1 (en) * | 2021-03-02 | 2022-09-09 | The Johns Hopkins University | Anti-fibrotic therapies |
CN113121505B (zh) * | 2021-03-02 | 2023-03-07 | 中国人民解放军海军军医大学 | 一种具有抗真菌与抗肿瘤双重作用的三唑酮类化合物及应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU621245B2 (en) * | 1989-10-17 | 1992-03-05 | Boehringer Mannheim Gmbh | Hydrolase substrates, a process for the preparation thereof and agents containing them |
JP4580932B2 (ja) * | 2003-06-12 | 2010-11-17 | メルク・シャープ・エンド・ドーム・コーポレイション | 有糸分裂キネシン阻害剤のプロドラッグ |
EP1817295B1 (en) * | 2004-11-18 | 2012-11-07 | Synta Pharmaceuticals Corp. | Triazole compounds that modulate hsp90 activity |
DE102005007304A1 (de) * | 2005-02-17 | 2006-08-24 | Merck Patent Gmbh | Triazolderivate |
US8399464B2 (en) | 2005-03-09 | 2013-03-19 | Nippon Kayaku Kabushiki Kaisha | HSP90 inhibitor |
EP1857446B1 (en) * | 2005-03-09 | 2013-05-01 | Nippon Kayaku Kabushiki Kaisha | Derivatives of 3-(2,4-dihydroxyphenyl)-1,2,4-triazole useful in the treatment of cancer |
AU2006272652B2 (en) * | 2005-07-25 | 2011-06-16 | Synta Pharmaceuticals Corp. | 1,2,3-triazoles inhibitors of tubulin polymerization for the treatment of proliferative disorders |
US20070219129A1 (en) * | 2005-08-17 | 2007-09-20 | Pritchard Kirkwood A Jr | hsp90 decoy peptides and uses thereof |
AU2006338265B2 (en) | 2005-08-18 | 2011-04-14 | Synta Pharmaceuticals Corp. | Triazole compounds that modulate HSP90 activity |
US8629285B2 (en) | 2005-08-18 | 2014-01-14 | Synta Pharmaceuticals Corp. | Imidazole compounds that modulate HSP90 activity |
CA2653332A1 (en) | 2006-05-25 | 2007-12-06 | Synta Pharmaceuticals Corp. | Triazole compounds that modulate hsp90 activity |
RS53446B (en) | 2006-05-25 | 2014-12-31 | Synta Pharmaceuticals Corp. | TRIAZOLE UNITS MODULATING HSP90 ACTIVITY |
TW200806637A (en) | 2006-05-25 | 2008-02-01 | Synta Pharmaceuticals Corp | Synthesis of triazole compounds that modulate HSP90 activity |
AU2007267847B2 (en) | 2006-05-25 | 2012-04-12 | Synta Pharmaceuticals Corp. | Triazole compounds that modulate Hsp90 activity |
DE102007002715A1 (de) * | 2007-01-18 | 2008-07-24 | Merck Patent Gmbh | Triazolderivat |
BRPI0815116A2 (pt) | 2007-08-13 | 2015-01-27 | Synta Pharmaceuticals Corp | Compostos de triazol que modulam a atividade da hsp90 |
-
2008
- 2008-08-13 BR BRPI0815116-4A2A patent/BRPI0815116A2/pt not_active IP Right Cessation
- 2008-08-13 US US12/673,254 patent/US8742133B2/en active Active
- 2008-08-13 AU AU2008287367A patent/AU2008287367B2/en not_active Ceased
- 2008-08-13 KR KR1020107005268A patent/KR20100057030A/ko not_active Application Discontinuation
- 2008-08-13 MX MX2010001565A patent/MX2010001565A/es active IP Right Grant
- 2008-08-13 JP JP2010521020A patent/JP5596543B2/ja not_active Expired - Fee Related
- 2008-08-13 EP EP08795272A patent/EP2193135A1/en not_active Withdrawn
- 2008-08-13 CA CA2695995A patent/CA2695995C/en not_active Expired - Fee Related
- 2008-08-13 WO PCT/US2008/009667 patent/WO2009023211A1/en active Application Filing
- 2008-08-13 CN CN200880102662.2A patent/CN101801983B/zh not_active Expired - Fee Related
- 2008-08-13 NZ NZ583205A patent/NZ583205A/en not_active IP Right Cessation
- 2008-08-13 TW TW097130768A patent/TWI438199B/zh not_active IP Right Cessation
-
2010
- 2010-02-02 IL IL203663A patent/IL203663A/en not_active IP Right Cessation
- 2010-02-12 ZA ZA201001064A patent/ZA201001064B/xx unknown
-
2014
- 2014-05-23 US US14/285,834 patent/US9120745B2/en active Active
-
2015
- 2015-08-27 US US14/837,875 patent/US20150366885A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2010536753A (ja) | 2010-12-02 |
NZ583205A (en) | 2012-03-30 |
US8742133B2 (en) | 2014-06-03 |
AU2008287367B2 (en) | 2012-02-23 |
US20110195094A1 (en) | 2011-08-11 |
US20140296186A1 (en) | 2014-10-02 |
BRPI0815116A2 (pt) | 2015-01-27 |
JP5596543B2 (ja) | 2014-09-24 |
AU2008287367A1 (en) | 2009-02-19 |
TW200911788A (en) | 2009-03-16 |
IL203663A (en) | 2015-08-31 |
CA2695995C (en) | 2015-09-29 |
WO2009023211A1 (en) | 2009-02-19 |
MX2010001565A (es) | 2010-04-27 |
CA2695995A1 (en) | 2009-02-19 |
US20150366885A1 (en) | 2015-12-24 |
EP2193135A1 (en) | 2010-06-09 |
CN101801983B (zh) | 2014-01-29 |
CN101801983A (zh) | 2010-08-11 |
TWI438199B (zh) | 2014-05-21 |
US9120745B2 (en) | 2015-09-01 |
KR20100057030A (ko) | 2010-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1137455A1 (en) | Triazole compounds that modulate hsp90 activity hsp90 | |
ZA201001064B (en) | Triazole compounds that modulate Hsp90 activity | |
SI2035396T1 (sl) | Triazolne spojine, ki modulirajo aktivnost HSP90 | |
PL2328893T3 (pl) | Związki triazolowe modulujące aktywność Hsp90 | |
IL183108A0 (en) | Triazole compounds that modulate hsp90 activity | |
EP2141990A4 (en) | ACTIVE COMPOUNDS ON 11BETA-HSD1 | |
EG26398A (en) | Insecticides | |
ZA201003937B (en) | Insecticidal compounds | |
GB0720232D0 (en) | Insecticidal compounds | |
EP2146771A4 (en) | INTRAKAVITARY RADIATION SYSTEM | |
IL200165A0 (en) | Compounds that inhibit cholinesterase | |
GB0704468D0 (en) | Insecticidal compounds | |
HK1146281A1 (en) | Trisubstituted 1,2,4-triazoles 124- | |
ZA200703956B (en) | Triazole compounds that modulate Hsp90 activity | |
AU2007904011A0 (en) | Reel for straps | |
IL182382A0 (en) | Distributed jammer system | |
GB0717339D0 (en) | Insecticidal compounds | |
GB0714571D0 (en) | Insecticidal compounds | |
GB0712793D0 (en) | Insecticidal compounds | |
GB0709351D0 (en) | Insecticidal compounds | |
GB0725219D0 (en) | Insecticidal compounds | |
GB0724757D0 (en) | Insecticidal compounds | |
GB0721001D0 (en) | Insecticidal compounds | |
GB0711732D0 (en) | Metal-organic compounds | |
GB0700283D0 (en) | Compounds |